DSM is a leading global solutions supplier to the Early Life Nutrition industry with a unique portfolio including nutritional lipids, vitamins and nutrient premixes. With the acquisition of Glycom, DSM adds HMOs to its portfolio. The high-growth HMO market is set to deliver novel ingredients for next generation Early Life Nutrition solutions.

Glycom is the only fully-integrated HMO provider in the world with its own product development, preclinical and clinical development, regulatory and large-scale production with an exciting innovation roadmap for next-generation HMOs. As HMOs are believed essential for the development of immunity, cognitive and digestive functions, there is significant interest in HMOs for the dietary supplement market, unmet medical nutrition needs like irritable bowel syndrome, food & beverage applications and for pet foods.

Attachments

  • Original document
  • Permalink

Disclaimer

Koninklijke DSM NV published this content on 01 April 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 April 2020 17:00:00 UTC